Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01649583 · ClinicalTrials.gov registry record · NA
Feasibility Study of Dynasplint to Prevent Trismus in Head and Neck Cancer
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01649583 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT01649583, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to see if use of a device called the Jaw Dynasplint® System can be used during and immediately after cancer treatment. The Dynasplint® is a stretching device that is used to treat joint stiffness and limited range of motion in the jaw. The device is currently approved for treatment of trismus once it has developed. This study will investigate the use of the device during and immediately after cancer treatment to prevent trismus.
Interventions
- DEVICE Jaw Dynasplint System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01649583
The ClinicalTrials.gov registry entry for NCT01649583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Jaw Dynasplint System is the first listed.
NCT01649583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01649583 about?
NCT01649583 is a clinical study titled "Feasibility Study of Dynasplint to Prevent Trismus in Head and Neck Cancer". The purpose of this study is to see if use of a device called the Jaw Dynasplint® System can be used during and immediately after cancer treatment. The Dynasplint® is a stretching device that is used to treat joint stiffness and limited range of motion in the jaw. The device is currently approved fo...
What is the current status of trial NCT01649583?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2012-08. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01649583?
The interventions under investigation include: Jaw Dynasplint System (DEVICE).
Who is sponsoring clinical trial NCT01649583?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.